Rett syndrome
Rett syndrome is a rare neurodevelopmental disorder, mainly affecting girls, caused usually by MECP2 gene mutations; it features developmental regression, loss of hand skills, movement problems and medical complications.
Overview
Rett syndrome is a rare, severe neurodevelopmental disorder that almost exclusively affects females. Children with Rett syndrome typically appear to develop normally for the first 6–18 months, then show a pattern of developmental stagnation and regression. Key features include loss of purposeful hand use, diminished spoken language, and distinctive repetitive hand movements.
Image gallery
3 ImagesSigns and characteristics
The clinical presentation is variable but often includes a combination of the following:
- Early normal growth followed by loss of acquired skills and slowed head growth
- Repetitive hand stereotypies such as wringing, clapping, or tapping
- Gait abnormalities or inability to walk
- Breathing irregularities (hyperventilation, breath-holding), seizures, and sleep problems
- Small hands and feet, scoliosis, and growth delay
Causes and diagnosis
Most cases are caused by mutations in the MECP2 gene on the X chromosome; the change usually occurs de novo rather than being inherited. Diagnosis combines clinical criteria with genetic testing to confirm an MECP2 mutation. Distinguishing Rett syndrome from autism spectrum disorders and other developmental conditions relies on the typical pattern of regression and the presence of hand stereotypies. For clinical guidelines and genetic resources see genetics information and diagnostic criteria.
Management and prognosis
There is no cure. Care is multidisciplinary and aims to improve quality of life through physiotherapy, occupational and speech therapy, nutritional and respiratory support, seizure control, and orthopedic management for scoliosis. Assistive communication devices and tailored educational programs can enhance interaction. Families often access support through specialist centers and advocacy groups; see care resources and support organizations for practical guidance.
History and research
Rett syndrome was first described in the 1960s and its genetic cause (MECP2) was identified in the late 1990s. Research continues into targeted therapies, including gene therapy and molecular approaches, but these remain experimental. Clinical trials and registries help track outcomes and advance understanding; see research updates.
Notable facts and distinctions
Rett syndrome is an X‑linked dominant disorder with a distinctive clinical course that separates it from many other developmental conditions. Males with MECP2 mutations are rare and usually present with more severe neonatal encephalopathy. Early recognition and coordinated care improve long-term support and planning; for family planning and genetic counseling information consult counseling resources.
Related articles
Author
AlegsaOnline.com Rett syndrome Leandro Alegsa
URL: https://en.alegsaonline.com/art/82355